AMARIN
CORPORATION PLC
|
(Translation
of registrant’s name into English)
|
110
Cannon Street, London EC4N 6AR, England
|
(Address
of principal executive offices)
|
Yes
o
|
No
x
|
Yes
o
|
No
x
|
Yes
o
|
No x
|
This
report on Form 6-K is hereby incorporated by reference in (a) the
registration statement on Form F-3 (Registration No. 333-104748) of
Amarin Corporation plc and in the prospectus contained therein,
(b) the registration statement on Form F-3 (Registration
No. 333-13200) of Amarin Corporation plc and in the prospectus
contained therein, (c) the registration statement on Form F-3
(Registration No. 333-12642) of Amarin Corporation plc and in the
prospectus contained therein, (d) the registration statement on Form
F-3
(Registration No. 333-121431) of Amarin Corporation plc and in the
prospectus contained therein, (e) the registration statement on Form
F-3
(Registration No. 333-121760) of Amarin Corporation plc and in the
prospectus contained therein, (f) the registration statement on Form
F-3
(Registration No. 333-135718) of Amarin Corporation plc and in the
prospectus contained therein and (g) the registration statement on
Form
F-3 (Registration No. 333-131479) of Amarin Corporation plc and in
the
prospectus contained therein, and this report on Form 6-K shall be
deemed
a part of each such registration statement from the date on which
this
report is filed, to the extent not superseded by documents or reports
subsequently filed or furnished by Amarin Corporation plc under the
Securities Act of 1933 or the Securities Exchange Act of
1934.
|
Exhibit
|
Description
|
99.1
|
Unaudited
Pro Forma Combined Condensed Consolidated Financial Information giving
effect to the acquisition by Amarin Corporation plc of all of the
outstanding shares of Ester Neurosciences
Ltd.
|
AMARIN
CORPORATION PLC
|
By: /s/
Tom
Maher
|
Tom
Maher
|
General
Counsel
|